So.Se.PHARM

What So.Se.PHARM does

So.Se.PHARM Srl is an Italian family-run pharmaceutical company founded in 1994 and headquartered in Pomezia (Rome), operating two EU-GMP and ISO 9001 certified production sites at Pomezia and Anagni. The company manufactures and packages branded generic prescription drugs across 22 therapeutic categories (antihypertensives, PPIs, analgesics, antibiotics, antidepressants, antiepileptics, among others), over-the-counter medicines, medical devices (including the SANISPIRA nasal air purifier line), and parapharmaceutical products (Floragyn, Emil, Eva/qu).

The business operates a hybrid model with two principal revenue engines. First, it markets proprietary branded generics, OTC, and consumer health products through a direct national distribution network reaching Italian pharmacies and hospitals, with international markets served through licensees and distribution partnerships. Second, it provides contract manufacturing and pharmaceutical development services — including pre-formulation, formulation, analytical method development, stability studies, and CTD/eCTD registration support — to approximately 60 Italian and international pharmaceutical companies, leveraging a maximum production capacity of 200 million units per year across solid oral, semi-solid, liquid, and injectable dosage forms (including dedicated beta-lactam lines). Current exploited capacity stands at approximately 90 million units per year, with a documented production mix dominated by beta-lactams (31%), coated tablets (19%), sachets (14%), capsules (12%), tablets (11%), and vials (10%).

Innovation is centered on a Molecular Farming research center at the Anagni site for biosimilar development using genetically modified plants (e.g., Rituximab), alongside a dedicated Bacillus Clausi raw material production line. The company is a member of Farmindustria and adheres to EFPIA transparency requirements, publishing annual transfers-of-value data. Pricing is constrained by AIFA regulation and is not publicly disclosed, in line with Italian pharmaceutical industry practice.

Name

So.Se.PHARM

Legal name

So.Se.PHARM Srl

Website

https://sosepharm.it

Company type

Private

Founded year

1994

Operating status

Operating

Headcount range

11–50 employees

Short description

So.Se.PHARM is an Italian family-run pharmaceutical company founded in 1994 that manufactures branded generic drugs, OTC medicines, medical devices, and parapharmaceuticals at EU-GMP and ISO 9001 certified facilities, distributing through Italian pharmacies and hospitals and via international licensees.

Ownership category

akta.pro rank

Headquarters

HQ city

Pomezia

HQ country

Italy

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Branded Generic Pharmaceutical Sales: Sale of prescription generic drugs under proprietary brand names in the Italian market through direct distribution to pharmacies and hospitals.
2. OTC Pharmaceutical Products: Branded over-the-counter medicines sold through pharmacy networks.
3. Medical Devices: Sale of medical devices including SANISPIRA nasal air purifiers and other healthcare products.
4. Food Supplements and Parapharmaceuticals: Dietary supplements and parapharmaceutical products including Floragyn, Emil, and Eva/qu product lines.
5. Contract Manufacturing: Contract manufacturing services for approximately 60 Italian and international pharmaceutical companies. Production capacity up to 200 million units per year.
6. International Licensing and Distribution: Products available internationally through network of licensees and distribution agreements with foreign companies.

Go-to-market motion3 records

Distribution channels4 records

Marketing channels3 records

Core offering

So.Se.PHARM is an Italian family-run pharmaceutical company that manufactures, packages, and distributes branded generic prescription drugs, over-the-counter (OTC) medicines, medical devices (notably the SANISPIRA nasal air purifier line), and food supplements. The company also provides contract manufacturing and pharmaceutical development services to approximately 60 Italian and international pharmaceutical companies from its EU-GMP and ISO 9001 certified production sites in Pomezia and Anagni.

Product overview

So.Se.PHARM Srl is an Italian family-run pharmaceutical company that operates as a manufacturer and distributor of generic prescription drugs (branded generics), OTC medications, medical devices, and food supplements. The product portfolio includes: (1) Generic pharmaceuticals organized by therapeutic categories including antihypertensives (FLORTITENS, IDROTENS, LANEX, LASTAN, LOZID, PRESSLOVAL, VALIDROC, CURCIX, CORAL), proton pump inhibitors (INIPANT, CLETUS), analgesics (PIRALGIN, KEVINDOL, ISOFENAL, DOMES, ARTROXICAM), antibiotics (AMOSOL, HOMER, TROZAMIL, CLAMODIN, KLIACEF, GENERFLON, CROMEZIN, TOTTIZIM, TAIPER, SIRTAP, BATIXIM, AMIKAN), antidepressants (FRIMAIND, GIACHELA), antiepileptics (ITALEPT), and others across 22 therapeutic categories; (2) Medical devices including the SANISPIRA nasal air purifier line with multiple variants; (3) Parafarmaceutica products including Floragyn intimate hygiene line, Emil dietary supplement for pregnancy nausea, and Eva/qu effervescent suppository for constipation. Products are distributed throughout Italy via a sales and distribution network including direct supplies to pharmacies and hospitals, and internationally through licensees and distribution agreements. Manufacturing is performed at EU-GMP and ISO 9001 certified facilities in Pomezia and Anagni, with maximum capacity around 200 million units per year.

Differentiator

Problem solved

Functional benefit

Products and services

• Branded Generic Prescription Pharmaceuticals A broad portfolio of branded generic prescription drugs covering 22 therapeutic categories, sold under proprietary brand names to Italian pharmacies and hospitals.
• OTC Medicines Branded over-the-counter (OTC) medicines marketed through Italian pharmacies for common self-treated conditions.
• SANISPIRA Nasal Air Purifiers A medical device line of nasal air purifiers available in variants including DOLCE NOTTE (night use), SMOG&ODORI (pollution and odors), ALLERGIA (allergy relief), and NASO CHIUSO (congestion relief), in sizes S, M, and L with 10 filters per pack.
• Floragyn Intimate Hygiene Line A feminine intimate hygiene product line classified as a cosmetic, designed for female intimate care across different life stages.
• Emil Dietary Supplement A dietary supplement in orodispersible tablet form designed for pregnancy-related nausea and vomiting, made from natural ingredients without pharmacological substances.
• Eva/qu Effervescent Suppository An effervescent suppository medical device for constipation relief made from natural, non-toxic substances suitable for adults including pregnant women.
• Contract Manufacturing Services Contract manufacturing services for pharmaceutical and medical device products at EU-GMP and ISO 9001 certified facilities, specializing in solid oral forms (tablets, coated tablets, capsules, sachets, effervescents), semi-solid forms (ovules, suppositories, creams, gels), liquid oral forms (drops, syrups, suspensions), and injectable forms including high-activity drugs such as beta-lactam antibiotics. Production capacity up to 200 million units per year, serving approximately 60 Italian and international pharmaceutical companies.
• Pharmaceutical Development Services Pharmaceutical development services including pre-formulation studies, formulation development, analytical development, validation activities, stability studies, clinical trial production, and registration dossier preparation in CTD and eCTD formats.

Quantifiable outcome

• Significant savings to healthcare systems through affordable generic medicines, enabling funding for more expensive new therapies
• +1 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• Farmindustria (Italian Pharmaceutical Industry Association)coreOthersSo.Se.PHARM is a member of Farmindustria, the Italian association of pharmaceutical companies. The company shares and practices the principles of the code of ethics including guidelines for certification procedures relating to scientific information activities (2013 edition and updates). Being a Farmindustria member requires compliance with transparency disclosure requirements under the EFPIA Code.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• STADA Arzneimittel: European-headquartered generic and consumer healthcare company with broad portfolio across multiple therapeutic categories. Highly comparable in terms of product breadth, generics focus, and European market orientation.
• IBSA Institut Biochimique: Swiss-headquartered pharmaceutical company with major Italian operations producing specialty pharmaceuticals, OTC, and medical devices. Comparable on geographic mix, diversified product portfolio, and mid-cap pharma manufacturer profile.
• Aenova Holding: European contract development and manufacturing organization (CDMO) offering solid, semi-solid, and liquid dosage forms. Directly comparable on the contract manufacturing and development services side of So.Se.PHARM's business.
• Recipharm: European CDMO providing pharmaceutical development and manufacturing services across multiple dosage forms. Comparable on contract manufacturing services and pharmaceutical development capabilities.
• Polpharma: Polish generic pharmaceutical manufacturer with broad European presence, producing generics, OTC, and APIs. Comparable in scale, generics focus, and contract manufacturing orientation.
• Doc Generici: Italian generic pharmaceutical manufacturer focused on prescription generics distributed through Italian pharmacies. Closest direct peer given shared geography, business model, and product overlap in the Italian branded-generics market.

Broad incumbents

• Sandoz (Novartis): Global generic and biosimilar division of Novartis, with strong European generics footprint. Overlaps with So.Se.PHARM's branded-generic portfolio and represents a major competitive benchmark.
• Teva Pharmaceutical Industries: World's largest generic drug manufacturer with a major Italian commercial presence. Competes with So.Se.PHARM across most of the same molecules but at materially larger scale and broader geographic footprint.
• Viatris: Global healthcare company formed by the Mylan-Upjohn combination, with significant European generic pharmaceutical operations. Competes in many of the same therapeutic categories as So.Se.PHARM.

Regional players

• Krka: Slovenian-headquartered generic pharmaceutical manufacturer with strong presence across Central and Eastern Europe. Similar product mix (generics, OTC) and European regional footprint, though outside Italy.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/sose-pharm

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about So.Se.PHARM